Literature DB >> 22922670

Contribution of endothelial progenitor cells to neovascularization (Review).

Da-Wei Li1, Zhi-Qiang Liu, Jun Wei, Ying Liu, Lin-Sen Hu.   

Abstract

Endothelial progenitor cells (EPCs) are a cell population mobilized from bone marrow into the peripheral circulation and recruited into sites of vessel injury to participate in blood vessel formation in both physiological and pathological conditions. Due to the lack of unique surface markers and different isolation methods, EPCs represent heterogeneous cell populations including cells of myeloid or endothelial origin. Evidence suggests that EPCs play a critical role in postnatal blood vessel formation and vascular homeostasis and provide a promising therapy for vascular disease. However, the mechanisms by which EPCs participate in new vessel formation are still incompletely understood. We review the process of EPCs in neovascularization including EPC mobilization, migration, adhesion and effect on new vessel formation, in an attempt to better understand the underlying mechanisms and to provide potential effective management for the treatment of patients with vascular disease.

Entities:  

Mesh:

Year:  2012        PMID: 22922670     DOI: 10.3892/ijmm.2012.1108

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  24 in total

Review 1.  Chemokine signaling in development and disease.

Authors:  John Wang; Holger Knaut
Journal:  Development       Date:  2014-11       Impact factor: 6.868

2.  TNF-α increases endothelial progenitor cell adhesion to the endothelium by increasing bond expression and affinity.

Authors:  Anthony R Prisco; Michael R Prisco; Brian E Carlson; Andrew S Greene
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-24       Impact factor: 4.733

3.  Differential characteristics and in vitro angiogenesis of bone marrow- and peripheral blood-derived endothelial progenitor cells: evidence from avian species.

Authors:  Q A Shah; X Tan; S Bi; X Liu; S Hu
Journal:  Cell Prolif       Date:  2014-05-13       Impact factor: 6.831

4.  Beneficial Effects of Angiotensin-(1-7) on CD34+ Cells From Patients With Heart Failure.

Authors:  Colleen T Cole-Jeffrey; Carl J Pepine; Michael J Katovich; Maria B Grant; Mohan K Raizada; Sugata Hazra
Journal:  J Cardiovasc Pharmacol       Date:  2018-03       Impact factor: 3.105

Review 5.  Neovascularization and tissue regeneration by endothelial progenitor cells in ischemic stroke.

Authors:  Ji Li; Yan Ma; Xiao-Hui Miao; Ji-Dong Guo; Da-Wei Li
Journal:  Neurol Sci       Date:  2021-07-03       Impact factor: 3.307

6.  Quantitative and functional characteristics of endothelial progenitor cells in newly diagnosed hypertensive patients.

Authors:  M Skrzypkowska; J Myśliwska; B Słomiński; J Siebert; P Gutknecht; M Ryba-Stanisławowska
Journal:  J Hum Hypertens       Date:  2014-10-09       Impact factor: 3.012

Review 7.  Migratory potential of transplanted glial progenitors as critical factor for successful translation of glia replacement therapy: The gap between mice and men.

Authors:  Rohit K Srivastava; Jeff W M Bulte; Piotr Walczak; Miroslaw Janowski
Journal:  Glia       Date:  2017-12-20       Impact factor: 7.452

8.  Exogenous endothelial progenitor cells reached the deficient region of acute cerebral ischemia rats to improve functional recovery via Bcl-2.

Authors:  Yan Hong; Qing Yu; Zhaohong Kong; Meiyao Wang; Renwei Zhang; Yan Li; Yumin Liu
Journal:  Cardiovasc Diagn Ther       Date:  2020-08

Review 9.  Role of Stromal Cell-Derived Factor-1 in Endothelial Progenitor Cell-Mediated Vascular Repair and Regeneration.

Authors:  Ji-Hua Li; Yang Li; Dan Huang; Min Yao
Journal:  Tissue Eng Regen Med       Date:  2021-08-27       Impact factor: 4.451

10.  Higher plasma level of STIM1, OPG are correlated with stent restenosis after PCI.

Authors:  Haibin Li; Zhian Jiang; Xiangdong Liu; Zhihui Yang
Journal:  Int J Clin Exp Med       Date:  2015-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.